University of Washington-Seattle Campus · BiologyDiabetes Biomarker Research Lab
Andrew N Hoofnagle · Seattle, Washington
Research Focus
Dr. Andrew N. Hoofnagle's lab at the University of Washington focuses on improving blood tests for patients with type 1 diabetes. Their research aims to make these tests more reliable and easier to reproduce in different labs, which is crucial for personalized medicine. By using advanced technologies like mass spectrometry, the lab seeks to better understand diabetes and improve the management of the disease through more accurate biomarkers.
protein quantificationtype 1 diabetesmass spectrometrybiomarkerspersonalized medicine
Research Aims
5AIM 01Develop novel protein assays using mass spectrometry.
AIM 02Validate sensitivity and specificity of blood tests.
AIM 03Enhance reproducibility of diabetes biomarkers across laboratories.
AIM 04Investigate the role of specific proteins related to type 1 diabetes.
AIM 05Facilitate the integration of assay findings into patient care.
Skills the Lab Values
mass spectrometryliquid chromatographyprotein assaysbiomarker developmentextracellular vesicle isolation
Output against the department
Publications440top 10% of dept.101st of 1,033
this lab
most publishedleast published
Citations22ktop 17% of dept.178th of 1,033
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.